Enterprise Pharma AI
ISMILE is not just another consultancy. We are the execution partner that bridges the gap between visionary AI strategy and secure, compliant production at scale in the pharmaceutical sector.
01 AI is stuck in experimentation
Creates Enterprise AI roadmaps, governance models, secure AI architecture, AI CoE support, human-in-the-loop workflows, and production-ready AI execution frameworks.
02 Data is fragmented across brands, channels, vendors, and systems
Builds Data Intelligence Platforms that unify CRM, CMS, DAM, MLR, media, analytics, marketing automation, and sales data into a governed intelligence layer.
03 Reporting exists, but intelligence is missing
Develops executive dashboards, predictive analytics, AI-assisted recommendations, next-best-action intelligence, and closed-loop reporting systems
04 The MarTech stack is fragmented, underused, or poorly architected
Designs AI-ready MarTech ecosystems with CRM, CMS, DAM, MLR, analytics, media, and marketing automation integrations.
05 Pharma marketing execution is fragmented
Connects planning, engagement strategy, content production, MLR readiness, analytics, reporting, and sales feedback loops into a unified workflow.
06 MLR review cycles are slowing execution
Implements pre-MLR readiness checks, content governance, version control, compliance checkpoints, and review-ready asset preparation.
07 AI introduces security and data exposure risk
Designs secure AI environments with role-based access controls, encryption, audit trails, monitoring, data isolation, and governance controls.
08 AI governance is unclear or inconsistent
Establishes AI governance frameworks, approval workflows, risk classification, auditability, prompt governance, and compliance checkpoints.
09 AI costs are difficult to control
Applies AI FinOps including usage monitoring, budget controls, cost optimization, ROI tracking, and cloud spend visibility.
10 Digital assets are spread across too many vendors and hosting environments
Provides secure managed pharma hosting, monitoring, backups, privacy controls, performance optimization, and web operations support.
11 Omnichannel execution is not truly connected
Connects websites, email, CRM, media, analytics, sales tools, and reporting into a unified omnichannel execution framework.
12 SaaS platforms do not fit pharma workflows
Builds custom execution platforms aligned to brand needs, therapy areas, compliance requirements, governance models, and commercial operations.
13 Legal, MSA, and AI addendum requirements are slowing AI adoption
Supports AI implementation planning around MSAs, SOWs, AI addendums, privacy requirements, vendor governance, and risk management.
14 AI Center of Excellence strategy is not reaching execution
Helps AI CoEs operationalize AI through reusable workflows, use-case prioritization, governance implementation, and business value measurement.
Most pharma AI initiatives fail in the transition from lab to production. Let’s ensure yours isn’t one of them.
Driving AI value with brilliant minds, alliances and global reach
Many pharma teams are testing AI through disconnected pilots, one-off use cases, isolated analytics initiatives, department-level automation, and experimental proof-of-concepts without a production roadmap. This often results in limited business impact, unclear governance, increased security risk, and no repeatable operating model. ISMILE helps organizations move from experimentation to governed enterprise AI execution.
Pharma organizations often have CRM, marketing, media, web analytics, sales, MLR, and engagement data spread across disconnected systems. This creates inconsistent reporting, limited customer visibility, and blocks AI initiatives because the data foundation is not ready. ISMILE helps build Data Intelligence Platforms that unify data and create a connected intelligence layer for commercial decision-making.
MLR bottlenecks are often caused by incomplete content submissions, missing references, unclear claims, inconsistent review workflows, poor traceability, manual version control, and late-stage compliance issues. ISMILE helps establish MLR-ready workflows, governance processes, and review readiness controls that improve submission quality and reduce delays.
Without proper controls, AI tools can expose sensitive information such as HCP data, patient support data, brand strategies, launch plans, sales performance data, market access information, MLR-sensitive content, and proprietary business information. ISMILE helps design secure enterprise AI workflows with data isolation, encryption, role-based access controls, audit trails, monitoring, and governance controls.
Many organizations lack a consistent AI use-case intake process, risk classification model, approval workflow, audit trail, human review requirements, prompt governance, and ownership structure across business, IT, legal, compliance, and security teams. ISMILE helps establish practical AI governance frameworks that provide control, transparency, accountability, and enterprise-scale adoption.
Didn’t find the answer you’re looking for?
Help us improve our knowledge base by submitting a question and suggested answer.
Our team will review your submission before publishing.
English
Indian English